https://www.indianpharmapost.com/moderna-sues-pfizer-biontech-for-mrna-patent-infringement-129162022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-international-forms-a-new-subsidiary-129242022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-receives-6-observations-from-usfda-for-goa-facility-129232022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-receives-oai-from-usfda-for-goa-facility-129222022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/philips-spotlights-integrated-data-driven-cardiology-solutions-at-esc-2022-129212022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/collective-efforts-needed-to-make-india-a-global-healthcare-leader-dr-mandaviya-129202022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-files-for-emergency-use-of-ba4ba5-omicron-booster-129192022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-to-spin-off-sandoz-business-to-a-standalone-company-129182022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/qdenga-approved-in-indonesia-for-use-regardless-of-prior-dengue-exposure-129172022-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-international-to-acquire-stake-in-o2-renewable-energy-ii-129252022-08-28T00:00:00+05:30always0.9